Pulmatrix (PULM) Receivables - Net (2014 - 2025)
Pulmatrix (PULM) posted Receivables - Net of $16000.0 for Q1 2025, down 30.43% sequentially from $23000.0 in Q3 2024, and down 97.19% YoY from $570000.0 in Q1 2024.
Pulmatrix (PULM) Receivables - Net (2014 - 2025) Analysis & Trends
Pulmatrix has reported Receivables - Net for 12 years, with the latest figure at $16000.0 in Q1 2025.
- Quarterly Receivables - Net fell 97.19% year-over-year to $16000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $16000.0 (down 97.19% YoY) and the FY2023 annual result came in at $928000.0, down 28.51% from the prior year.
- Receivables - Net retreated to $16000.0 in Q1 2025 per PULM's latest filing, from $23000.0 in the prior quarter.
- Over five years, Receivables - Net peaked at $1.8 million in Q2 2021 and troughed at $9000.0 in Q3 2021.
- A 5-year average of $602000.0 and a median of $602500.0 in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2021 and 2022: Receivables - Net tumbled 99.26% in 2021, then soared 5188.89% in 2022.
- Over 5 years, Receivables - Net stood at $67000.0 in 2021, then soared by 1837.31% to $1.3 million in 2022, then slipped by 28.51% to $928000.0 in 2023, then slumped by 97.52% to $23000.0 in 2024, then tumbled by 30.43% to $16000.0 in 2025.
- According to Business Quant data, Receivables - Net over the past three periods registered $16000.0, $23000.0, and $635000.0 for Q1 2025, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - |
| 10 | Pulmatrix | 5.55 Mn | 5.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Sep 30, 2024 | 23,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Jun 30, 2024 | 635,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 928,000.00 |
| Dec 31, 2023 | 928,000.00 |
| Sep 30, 2023 | 841,000.00 |
| Sep 30, 2023 | 841,000.00 |
| Jun 30, 2023 | 418,000.00 |
| Jun 30, 2023 | 418,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Mar 31, 2023 | 740,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 476,000.00 |
| Sep 30, 2022 | 476,000.00 |